|

Bleomycin Clinical Trials

6 actively recruiting trials across 1 location

Also known as: ABVD, BLEO, BLM, Blanoxan

Pipeline

Phase 2: 1Phase 3: 4Phase 4: 1

Top Sponsors

  • Beihua Kong2
  • University College, London1
  • State Budgetary Healthcare Institution, National Medical Surgical Center N.A. N.I. Pirogov, Ministry of Health of Russia1
  • Julie Gehl1
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna1

Indications

  • Cancer6
  • Ovarian Neoplasms2
  • Ovarian Cancer2
  • Ovarian Sex Cord Stromal Tumor1
  • Ovarian Germ Cell Cancer1

Other5 trials

Electrochemotherapy With Carboplatinum Plus Bleomycin Versus Bleomycin Alone in Vulvar Cancer
Phase 2
First Line Chemotherapy for Classical Hodgkin Lymphoma in Russia (HL-Russia-1)
Phase 3
TC or BEP in Treating Patients With Malignant Ovarian Germ Cell Tumors
Phase 3
TC or BEP in Treating Patients With Ovarian Malignant Sex Cord-Stromal Tumors
Phase 3
The Effect of Reduced Bleomycin in Electrochemotherapy Treatment
Phase 4

Stanford, California1 trial

Brentuximab Vedotin in Early Stage Hodgkin Lymphoma

Stanford University - (Stanford Cancer Institute)

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.